August 31, 2016 3:01 AM ET

Biotechnology

Company Overview of DermTech, Inc.

Key Executives for DermTech, Inc.

NameBoard RelationshipsTitleAge
John D. Dobak M.D.14 RelationshipsChief Executive Officer, President and Director50
Steven J. Kemper CPA, MBANo RelationshipsChief Financial Officer, Principal Financial & Accounting Officer, Secretary and Treasurer60
Michael Willis Ph.D.No RelationshipsChief Operating Officer52
Burkhard Jansen M.d.12 RelationshipsChief Medical Officer--

DermTech, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Gary E. Jacobs 94 RelationshipsDermTech, Inc.59
John D. Dobak M.D. 14 RelationshipsDermTech, Inc.50
Scott R. Pancoast 17 RelationshipsVectra LLC58
Carl C. Peck M.D., Dr h.c. (Uppsala) 53 RelationshipsNDA Partners LLC74
William Wachsman M.D., Ph.D. 10 RelationshipsDermTech, Inc.--
View All Board Members

DermTech, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Scott R. Pancoast17 Relationships2 Executives
Compensation Committee Scott R. Pancoast17 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$251.6K
251.6K
380.3K
Bonus$36.9K
36.9K
264.6K
Total Short Term Compensation
Not meaningful
Total Value of Options$288.5K
288.5K
33.9M
Compensation as of Fiscal Year 2013
DermTech, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Bone Therapeutics SA Appoints Benoît Champluvier as Chief Technology and Manufacturing Officer
August 30, 2016 5:00 AM ET
Adverum Biotechnologies, Inc. Announces Resignation of John P. McLaughlin as Member of the Board of Directors, Chairman and Member of the Audit Committee and Member of the Compensation and Nominating and Corporate Governance Committees of the Board, Effective as of August 31, 2016
August 29, 2016 8:44 PM ET
OncoCyte Corporation Announces Board Changes
August 29, 2016 8:15 PM ET
Leap Therapeutics, Inc. and Macrocure Ltd. Announce Management Changes
August 29, 2016 12:51 PM ET
FORMA Therapeutics, Inc. Appoints Karoline Shair as Vice President, Legal and Chief Intellectual Property Counsel
August 29, 2016 12:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact DermTech, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.